Biolex Therapeutics applies its unique drug development capabilities to commercialize proteins and monoclonal antibodies that have been impossible or very expensive to develop through traditional means.  Biolex has developed the LEX System, a proprietary protein expression platform which couples natural characteristics of the small green aquatic plant, Lemna, with advanced genetic engineering and protein recovery methods.  Biolex is developing an internal pipeline of protein therapeutics and has also established strategic partnerships with a number of leading pharmaceutical and biotech companies.